Successful tocilizumab treatment in a child with refractory Takayasu arteritis

Pediatrics

Volumn 130, Issue 6, 2012, Pages

  Bravo Mancheño, Beatriz ^a   Perin, Francesca ^a   Vázquez Del Rey, María Del Mar Rodríguez ^a   García Sánchez, Antonio ^a   Alcázar Romero, Pedro Pablo ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Cyclophosphamide; Interleukin 6; Methotrexate; Mycophenolate mofetil; Pediatrics; Takayasu arteritis; TNF ; Tocilizumab; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; INTERLEUKIN 6; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; SERUM AMYLOID P; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA;

AORTA ARCH ANOMALY; AORTA ARCH SYNDROME; ARTICLE; BLOOD PRESSURE VARIABILITY; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY STENTING; CASE REPORT; CHILD; CLINICAL FEATURE; DIZZINESS; DOPPLER FLOWMETRY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEART MURMUR; HUMAN; HYPERTENSION; HYPOFIBRINOGENEMIA; INFECTION; INFUSION RELATED REACTION; MAGNETIC RESONANCE ANGIOGRAPHY; MICROCYTIC ANEMIA; OSTEOPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RELAPSE; RETROSTERNAL PAIN; THROMBOCYTOSIS; TRANSITIONAL BLINDNESS; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 84870502920     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-1384     Document Type: Article

References (15)

1. Ozen S, Pistorio A, Iusan SM, et al Paediatric Rheumatology International Trials Organisation (PRINTO). EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010;69(5):798-806
2. Brunner J, Feldman BM, Tyrrell PN, et al. Takayasu arteritis in children and adolescents. Rheumatology (Oxford). 2010;49(10):1806-1814
3. Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55(7):481-486 (Pubitemid 34779296)
4. Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and followup of large-vessel vasculitis: an update. Rheumatology (Oxford). 2008;47(4):403-408
5. Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS. Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum. 1994;37(4):578-582 (Pubitemid 24115946)
6. Ozen S, Duzova A, Bakkaloglu A, et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr. 2007;150(1):72-76 (Pubitemid 44940894)
7. Shinjo SK, Pereira RMR, Tizziani VAP, Radu AS, Levy-Neto M. Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol. 2007;26(11):1871-1875 (Pubitemid 47516967)
8. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50(7):2296-2304 (Pubitemid 38924409)
9. Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis. 2008;67(11):1567-1569
10. Park MC, Lee SW, Park YB, Lee SK. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis. Rheumatology (Oxford). 2006;45(5):545-548
11. Seko Y, Sato O, Takagi A, et al. Restricted usage of T-cell receptor Valpha-Vbeta genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis. Circulation. 1996;93(10):1788-1790 (Pubitemid 26154028)
12. Nishimoto N, Nakahara H, Yoshio-Hoshino N, Mima T. Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthritis Rheum. 2008;58(4):1197-1200 (Pubitemid 351564023)
13. Seitz M, Reichenbach S, Bonel HM, Adler S, Wermelinger F, Villiger PM. Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly. 2011;141:w13156
14. Salvarani C, Magnani L, Catanoso M, et al. Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology (Oxford). 2012;51(1):151-156
15. Tyagi S, Verma PK, Gambhir DS, Kaul UA, Saha R, Arora R. Early and long-term results of subclavian angioplasty in aortoarteritis (Takayasu disease): comparison with atherosclerosis. Cardiovasc Intervent Radiol. 1998;21(3):219-224 (Pubitemid 28257684)